Atomoxetine for Children and Adolescents: An Update
The Carlat Child Psychiatry Report, Volume 13, Number 1&2, January 2022
https://www.thecarlatreport.com/newsletter-issue/ccprv13n1-2/
Issue Links: Learning Objectives | Editorial Information
Topics: ADHD | Atomoxetine (ATX) | Attention Deficit Hyperactivity Disorder
Mikveh Warshaw, NP.
Psychiatric mental health nurse practitioner, Community Health Center Inc. and faculty member of Center for Key Populations (CKP) Program, Middletown, CT.
Ms. Warshaw has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Atomoxetine (ATX) has been available for about 20 years to treat ADHD in children and adolescents. But does it work? If so, what is its place in treatment? We talk about the relative efficacy of ATX and clinical situations where ATX has specific advantages.
You can't view details of this content, please login or buy subscription here